Puma Biotechnology

We focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.
Type
Public
HQ
Los Angeles, US
Founded
2010
Size (employees)
160 (est)+3%
Puma Biotechnology was founded in 2010 and is headquartered in Los Angeles, US

Key People at Puma Biotechnology

Alan H. Auerbach

Alan H. Auerbach

Chief Executive Officer, President
Troy Wilson

Troy Wilson

Director

Puma Biotechnology Office Locations

Puma Biotechnology has offices in Los Angeles, San Francisco and South San Francisco
Los Angeles, US (HQ)
10880 Wilshire Blvd

Puma Biotechnology Metrics

Puma Biotechnology Financial Metrics

Net income (FY, 2013)

($139.3 m)

EBIT (FY, 2013)

($139.4 m)

Market capitalization (28-Apr-2017)

$1.5 b

Closing share price (28-Apr-2017)

$40

Cash (31-Dec-2016)

$194.5 m
Puma Biotechnology's current market capitalization is $1.5 b.
FY, 2013

Operating expense total

$139.4 m

EBIT

($139.4 m)

Net Income

($139.3 m)
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$43 m$38.5 m$31.6 m$194.5 m

Accounts Receivable

Inventories

Current Assets

$96.4 m$149.4 m$223.5 m$236.5 m

PP&E

$1.7 m$2.2 m$2.4 m$5.2 m

Total Assets

$104.4 m$162.8 m$239.8 m$252.8 m

Accounts Payable

$10.7 m$15 m$17.8 m$20 m

Current Liabilities

$19.3 m$44.4 m$32.4 m$37.5 m

Additional Paid-in Capital

$223.2 m$399.2 m$726.7 m$1 b

Retained Earnings

($281.2 m)($520.5 m)($796.5 m)

Total Equity

$84 m$117 m$206 m$209.8 m

Financial Leverage

1.2 x1.4 x1.2 x1.2 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($54.7 m)($142 m)($239.3 m)($276 m)

Depreciation and Amortization

$423 k$627 k$776 k$1.1 m

Accounts Receivable

Inventories

Accounts Payable

$10.2 m$4.3 m$2.8 m$2.2 m

Cash From Operating Activities

($55 m)($77.2 m)($154.5 m)($141.7 m)

Purchases of PP&E

($624 k)($1.1 m)($1 m)($4.3 m)

Cash From Investing Activities

($41.5 m)($63.3 m)($85.9 m)$142.2 m

Cash From Financing Activities

$2.2 m$136 m$233.4 m$162.4 m
Y, 2016

Financial Leverage

1.2 x

Puma Biotechnology Market Value History

Puma Biotechnology News

Puma Biotechnology Company Life

You may also be interested in